CompletedPhase 3

Study of Antidepressants in Parkinson's Disease

NCT00086190

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

University of California San Francisco

San Francisco, California, United States

+17 additional locations

Save this trial

University of California San FranciscoSan Francisco, California, United States
University of FloridaGainesville, Florida, United States
University of MiamiMiami, Florida, United States
Emory University School of MedicineAtlanta, Georgia, United States
University of KentuckyLexington, Kentucky, United States
Johns Hopkins UniversityBaltimore, Maryland, United States
University of MarylandBaltimore, Maryland, United States
Beth Israel Deaconess Medical Center, Dept. of Neurology E/KS 430, 330 Brookline AvenueBoston, Massachusetts, United States
Washington University School of MedicineSt Louis, Missouri, United States
University of RochesterRochester, New York, United States
Medical University of OhioToledo, Ohio, United States
Oregon Health Sciences UniversityPortland, Oregon, United States
University of Tennessee-MemphisMemphis, Tennessee, United States
Baylor College of Medicine, 6550 Fannin, Suite 1801Houston, Texas, United States
University of VirginiaCharlottesville, Virginia, United States
London Health Sciences Centre, University Campus Room A10-325, 339 Windermere RoadLondon, Ontario, Canada
Hotel-Dieu Hospital-CHUMMontreal, Quebec, Canada
University of Puerto RicoSan Juan, Puerto Rico